Examine This Report on Myositis Therapy center in delhi/india
Rituximab can be a chimeric monoclonal antibody against the CD20 antigen expressed within the surface of B lymphocytes resulting in their depletion in the peripheral blood. a number of situation experiences, case collection and open-label trials have instructed a useful effect of rituximab in individuals with refractory myositis (latest overview in